Promising outlook for prognostic biomarkers related to Heart Failure with Preserved Ejection Fraction (HFpEF)
The production cycle from antibody-design to assay production is a collaboration between the research groups in RnD (and a potential sponsor) and the Antibody Research Unit (ARU) and the Technology Evaluation and Automation (TEA) group, which helps to facilitate and streamline the antibody development and assay production in RnD. There is a large degree of communication between the individual research groups and ARU and TEA to ensure the best design and development of our assays, as well as an thorough and precise final validation before the assay is transferred to our GMP production for large-scale manufacturing.
No event found
Please don't hesitate to contact us if you have any questions or other inquiries.